CD226 and lung cancer: Flow cytometry showed that hypoxic lung cancer cell-derived EVs decreased the expression of CD226 on NK cells (Figure 1d), suggesting that hypoxic CL1-5-derived EVs downregulated the activating receptor CD226 and thereby impair the cytotoxicity of NK cells.